- Cambridge, GB William Brady - Seattle WA, US Gordon King - Seattle WA, US Natalie Winblade Nairn - Seattle WA, US Kurt David Shanebeck - Seattle WA, US Paul Heffner Slagle - Seattle WA, US Kenneth Christopher Thornton - Seattle WA, US Michael Peter Vanbrunt - Seattle WA, US Andrea Wang - Seattle WA, US Hengyu Xu - Seattle WA, US
International Classification:
C07K 16/24
Abstract:
The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 and anti-IL-23 antibodies.
Kenneth GRABSTEIN - Seattle WA, US William BRADY - Seattle WA, US Gordon KING - Seattle WA, US Natalie Winblade NAIRN - Seattle WA, US Kurt David SHANEBECK - Seattle WA, US Paul Heffner SLAGLE - Seattle WA, US Kenneth Christopher THORNTON - Seattle WA, US Michael Peter VANBRUNT - Seattle WA, US Andrea WANG - Seattle WA, US Hengyu XU - Seattle WA, US
International Classification:
C07K 16/46
US Classification:
4241361, 5303873, 5303919
Abstract:
The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 antibodies and anti-IL-23 antibodies.